Sars-CoV2 Antibody Responses in Patients with Hematological Malignancies Following Anti-CD20 Therapy

Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with increased mortality in patients with hematological malignancies, with increase rates between 33-37%. Vaccination against SARS-CoV-2 have shown efficacy decreasing infection rates, with efficacy ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerra, Veronica A, Ocampo, Marisol, Cusnir, Mike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
623.Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701424/
http://dx.doi.org/10.1182/blood-2021-154090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701424/
http://dx.doi.org/10.1182/blood-2021-154090

Ejemplares similares